Authors: Asier Rabasco1,2, Alex Zwanenburg1,3,4, Annett Linge1,3,4,5, Fabian Lohaus1,3,4,5, Marianne Grosser6, Gustavo Baretton3,4,6,7, Goda Kalinauskaite8,9, Inge Tinhofer8,9, Nika Guberina10,11, Maja Guberina10,11, Panagiotis Balermpas12,13, Jens von der Grün12,13, Ute Ganswindt14,15,16,17, Claus Belka14,15,16, Jan C. Peecken14,18,19, Stephanie E. Combs14,18,19, Simon Böcke20,21, Daniel Zips20,21, Michael Baumann1,2,3,4,5,22, Esther G.C. Troost1,2,3,4,5, Mechthild Krause1,2,3,4,5, Steffen Löck1,3,5
1OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany; 2Institute of Radiooncology – OncoRay, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany; 3German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany; 4National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany; 5Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus- Technische Universität Dresden, Dresden, Germany; 6Institute of Pathology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; 7Tumour- and Normal Tissue Bank, University Cancer Centre (UCC), University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; 8German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany; 9Department of Radiooncology and Radiotherapy, Charité University Medicine Berlin, Berlin, Germany; 10German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK), Partner Site Essen, Essen, Germany; 11Department of Radiotherapy, University Hospital Essen, Medical Faculty, University of Duisburg-Essen, Essen, Germany; 12German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany; 13Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany; 14German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany; 15Department of Radiation Oncology, Ludwig-Maximilians-Universität, Munich, Germany; 16Clinical Cooperation Group, Personalized Radiotherapy in Head and Neck Cancer, Helmholtz Zentrum Munich, Munich, Germany; 17Department of Radiation Oncology, Medical University of Innsbruck, innsbruck, Austria; 18Department of Radiation Oncology, Technische Universität München, Munich, Germany; 19Institute of Radiation Medicine (IRM), Helmholtz Zentrum München, Neuherberg, Germany; 20German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK), Partner Site Tübingen, Tübingen, Germany; 21Department of Radiation Oncology, Faculty of Medicine and University Hospital Tübingen, Eberhard Karls Universität Tübingen, Tübingen, Germany; 22German Cancer Research Center (DKFZ), Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany
Show Affiliations
Hide Affiliations